Markets · 1 sources covering this

Xerox Shareholder Pushes for Activist Changes at Company

A significant shareholder in Xerox Holdings Corp. is pushing the company to take action to unlock shareholder value and is asking for a strategic review of its financial services business.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

BloombergLean L·2h ago
Xerox Shareholder Pushes for Activist Changes at Company
A significant shareholder in Xerox Holdings Corp. is pushing the company to take action to unlock shareholder value and is asking for a strategic review of its financial services business.
Read at Bloomberg →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/b9c8d578eb2d495ab7db6ceb3894665f9b592af5"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Xerox Shareholder Pushes for Activist Changes at Company"></iframe>

Xerox Shareholder Pushes for Activist Changes at Company

How 1 sources are covering this

Xerox Shareholder Pushes for Activist Changes at Company

More from Markets

OPEC Output Slumps as Conflict Curbs Saudi Flows, Survey Shows

Novartis’s failed trial for cholesterol drug leads to broad biopharma selloff

How to create a ‘forever paycheck’ without paying for an annuity

Qualcomm’s stock climbs as Amazon chip deal offers investors some much-needed good news

Reader

Trust & legal

Across the network

How 1 sources are covering this

Xerox Shareholder Pushes for Activist Changes at Company

More from Markets

OPEC Output Slumps as Conflict Curbs Saudi Flows, Survey Shows

Novartis&#x2019;s failed trial for cholesterol drug leads to broad biopharma selloff

How to create a &#x2018;forever paycheck&#x2019; without paying for an annuity

Qualcomm&#x2019;s stock climbs as Amazon chip deal offers investors some much-needed good news

Reader

Trust & legal

Across the network

Novartis’s failed trial for cholesterol drug leads to broad biopharma selloff

How to create a ‘forever paycheck’ without paying for an annuity

Qualcomm’s stock climbs as Amazon chip deal offers investors some much-needed good news